UC
Prevalence
32.8 / 100K
Incidence
3.3 / 100K/yr
740 drugs in development·306 companies·0 clinical trials
Drug Pipeline by Phase
Approved(310)
Phase 3(95)
Phase 2(86)
Phase 1(66)
Preclinical(40)
Unknown(80)
Early Phase 1(3)
N/A(2)
Phase 1/Phase 2(19)
Phase 2/Phase 3(8)
Phase 4(31)
Compare drugs
Frequently asked questions
How many drugs are in development for UC?
BioSniper tracks 740 drugs in development for UC across 306 companies.
What is the prevalence of UC?
The estimated prevalence of UC is approximately 32.8 per 100,000 population.
Deep-dive into UC
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis